FEATURED RESEARCHER: Meet Dr. Elizabeth Finger
Patience.
This is how Elizabeth Finger, M.D., principal investigator of FOXY: A Phase 2 Clinical Trial of Intranasal Oxytocin for Frontotemporal Dementia (FTD), handles this ...more >
FEATURED STUDY: FOXY-Intranasal Oxytocin for FTD
Having a specific treatment to address behavioral issues in persons diagnosed with frontotemporal degeneration (FTD) would provide some much-needed relief and may help return quality of life to...more >
FTD Registry Surpasses 4,200 before 4th Anniversary: March 28, 2021
Highlights from 2020, a historic year!
As the FTD Disorders Registry (FTDDR) reached its 4th Anniversary on March 28, 2021, we continue to surpass enrollment...more >
Registry Improves Registration Process and Updates Registrant Features in 2021
Changes improve user experience and collect additional data
Last month the FTD Disorders Registry launched a revised registration process to streamline the...more >
AFTD 2021 Education Conference: May 13-14, 2021
The AFTD 2021 Education Conference was held virtually on May 13 and 14, 2021, from 12:00 to 4:00 p.m. Eastern time (9:00 a.m. to 1:00 p.m. Pacific). recordings of the sessions are available...more >